Literature DB >> 11440466

Recent developments in non-excitable cell calcium entry.

A C Elliott1.   

Abstract

Influx of calcium into cells following stimulation of cell surface receptors is a key process controlling cellular activity. However, despite intensive research, there is still no consensus on precisely how calcium entry is controlled in electrically no n-excitable cells. In particular, the regulation of depletion-activated or 'capacitative' calcium entry continues to be a focus of debate. Work published in the last 2 years has lent new impetus to the so-called 'conformational coupling' theory, although evidence for the existence of soluble messengers between the ER and the plasma membrane also continues to appear. In addition, there remains disagreement on whether intra-store [Ca(2+)] has to fall below a threshold before Ca(2+)entry is activated. A further major question is the identity of the putative depletion-operated Ca(2+)channel or channels. Here discussion has largely focussed on whether homologue(s) of the Drosophila TRP ('Transient Receptor Potential') protein is/are the elusive channel, or at least a part of it. Finally, it remains possible that Ca(2+)entry mechanisms other than depletion-activated channels may be important in agonist-evoked Ca(2+)influx. This commentary summarizes recent developments in the field, and highlights both current debates and critical unsolved questions. Copyright 2001 Harcourt Publishers Ltd.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11440466     DOI: 10.1054/ceca.2001.0215

Source DB:  PubMed          Journal:  Cell Calcium        ISSN: 0143-4160            Impact factor:   6.817


  22 in total

Review 1.  Calcium channels in lymphocytes.

Authors:  G Grafton; L Thwaite
Journal:  Immunology       Date:  2001-10       Impact factor: 7.397

2.  Actin filaments play a permissive role in the inhibition of store-operated Ca2+ entry by extracellular ATP in rat brown adipocytes.

Authors:  Mariko Omatsu-Kanbe; Masaru Shibata; Takefumi Yamamoto; Takahiro Isono; Hiroshi Matsuura
Journal:  Biochem J       Date:  2004-07-15       Impact factor: 3.857

Review 3.  Taming the neutrophil: calcium clearance and influx mechanisms as novel targets for pharmacological control.

Authors:  G Tintinger; H C Steel; R Anderson
Journal:  Clin Exp Immunol       Date:  2005-08       Impact factor: 4.330

4.  New molecular players in capacitative Ca2+ entry.

Authors:  James W Putney
Journal:  J Cell Sci       Date:  2007-05-03       Impact factor: 5.285

5.  Maintenance of the filamentous actin cytoskeleton is necessary for the activation of store-operated Ca2+ channels, but not other types of plasma-membrane Ca2+ channels, in rat hepatocytes.

Authors:  Ying-Jie Wang; Roland B Gregory; Greg J Barritt
Journal:  Biochem J       Date:  2002-04-01       Impact factor: 3.857

6.  TRPC6 regulates cell cycle progression by modulating membrane potential in bone marrow stromal cells.

Authors:  Jun Ichikawa; Ryuji Inoue
Journal:  Br J Pharmacol       Date:  2014-12       Impact factor: 8.739

7.  Sources of calcium in agonist-induced contraction of rat distal colon smooth muscle in vitro.

Authors:  Hua Zhou; De-Hu Kong; Qun-Wan Pan; Hai-Hua Wang
Journal:  World J Gastroenterol       Date:  2008-02-21       Impact factor: 5.742

8.  Identification of store-independent and store-operated Ca2+ conductances in Caenorhabditis elegans intestinal epithelial cells.

Authors:  Ana Y Estevez; Randolph K Roberts; Kevin Strange
Journal:  J Gen Physiol       Date:  2003-07-14       Impact factor: 4.086

9.  Inositol 1,4,5-trisphosphate signaling regulates rhythmic contractile activity of myoepithelial sheath cells in Caenorhabditis elegans.

Authors:  Xiaoyan Yin; Nicholas J D Gower; Howard A Baylis; Kevin Strange
Journal:  Mol Biol Cell       Date:  2004-06-11       Impact factor: 4.138

10.  Pharmacological control of neutrophil-mediated inflammation: strategies targeting calcium handling by activated polymorphonuclear leukocytes.

Authors:  Gregory R Tintinger; Helen C Steel; Annette J Theron; Ronald Anderson
Journal:  Drug Des Devel Ther       Date:  2009-02-06       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.